ReviewClinical ophthalmology (Auckland, N.Z.)2022

Utilization of Modified Induced Pluripotent Stem Cells as the Advance Therapy of Glaucoma: A Systematic Review.

Diondra Eka Rizkiawan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.